ReviewJournal of advanced research2026
Integrating biocatalysis with continuous flow: current status, challenges, and future perspectives.
Review in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Liquid-Liquid Phase Separation-Enhanced Multienzyme Catalysis: Mechanisms and Applications.ChemSusChem · 2026Review
- Continuous and Divergent Biotransformation of β-Ketoesters Into Enantiomerically Pure β-Hydroxyacids or Their Oligomers Through a Telescoped Multienzyme Cascade.Chembiochem : a European journal of chemical biology · 2026Article
- 3D-Printed Platforms for Enzyme Immobilisation Screening and Direct Translation into Continuous-Flow Biocatalysis.ChemSusChem · 2026Article
- Biocatalyzed aza-michael additionRSC advances · 2026Article
- Industrial and Environmental Applications of Carbonic Anhydrases.Sub-cellular biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundContinuous-flow biocatalysis is gaining attention for the synthesis of highly valuable pharmaceuticals and fine chemicals. The integrated approach combines the high activity and selectivity of biocatalysts with the superior efficiency in mass and heat transfer of continuous-flow systems. Considerable progress has been made in the continuous-flow biocatalysis, but there are only a few reviews on the specific challenges and strategies encountered in continuous-flow reactions involving different biocatalysts. AIM OF REVIEW: This review aims to present a general overview of the implementation of various biocatalysts in continuous-flow systems for synthetic applications, and their specific issues and strategies associated with each category were discussed in detail. Future directions for biocatalysis in continuous flow, including current problems and potential strategies were proposed to offer insights and support for the advancement of continuous-flow biocatalysis. KEY SCIENTIFIC CONCEPTS OF REVIEW: Recent advances in continuous-flow biocatalysis were summarized according to the types of biocatalysts involved, encompassing single enzymes, multienzyme catalysts, whole-cell catalysts, metal-enzymatic catalysts, and organo-enzymatic catalysts, along with their combination with photocatalysis and electrocatalysis. The main challenges faced by diverse biocatalysts in continuous-flow processes have been systematically discussed, including poor substrate solubility with lipases, low oxygen availability for oxidoreductases, cofactor regeneration, catalyst leaching, as well as incompatibility problems in multi-enzyme cascade catalysis, and biocatalysis coupling with chemo-catalysis or other catalysis. Various strategies have been developed for addressing these challenges, such as construction of continuous-flow biphasic systems, design of self-sufficient biocatalysts, easy preparation of bioreactors mediated by fusion-tag. Future researches should focus on machine learning-assisted protein engineering and materials design, as well as computer-aided optimization of continuous-flow cascade systems, to reduce enzyme activity loss due to immobilization, and address mismatches between multiple enzymes and chemo-/photocatalysts in cascade processes, thereby developing sustainable, efficient, and industrially viable processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.